ISO14971-2019中文版
合集下载
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
• 1范围·······································································································1 • 2 规范性弓 I用文件···················································································1 • 3术语和定义····························································································1 • 4 .7 风险管理体系的—般要求………………………………………………………… • 4.1 风险管理流程 ··7 ............…..……............…..…….......…..…·…..…...…..… • 4.2 管理职责···························································································8 • 4.3 9 人员能力............................................................................................ • 4.4 g 风险管理计划.............…………...........…...…..............…·……...…......... • 4.5 风险管理文件…..........…..……….........…...………........…·……..…········10 • 5 风险分析 ····························································································10 • 5.1 风险分析过程…..........…..……............…...……...............……...…·······10 • 5.2 预期用途和合理可预见的滥用……………………………………………·10 • 5.3 识别与安全有关的特性………………………………………………………··11 • 5.4 识别危害和危险情况…..………........…...………........…·……·············11 • 5.5风险估算··························································································11 • 6 风险评估····························································································12 • 7 风险控制·····························································································12 • 7.1 风险控制方案分析......…………..........…..……...….....…...………········13 • 7.2 实施风险控制措施.........…….............…..……...…...........……···········13 • 7.3 残留风险评估················································································13
国际标准
ISO 标准 14971
第三版
2019-12
医疗设备—风险管理在医疗设备中的应用
曰四小
版权保护的文件
©ISO 2019
版权所有。 除非另有说明, 或者在实施时需要,否则,未经事先书面许 可,不得以任何形式或手段,通过电子或机械手段(包括影印或在互联 网或内部网上发布)以任何形式复制或使用本出版物的任何部分。 书面 许可。 可以从以下地址的ISO或请求者所在国家的ISO成员体内请求 许可。 ISO版权局 CP 401•章de Blandonnet 8 CH-1214 Vernier, 日内瓦 电话: +41 22 749 01 11 传真: +41 22 749 09 47 电子邮件: copyright@ 网站: 在瑞士出版
• 7.4 利益风险分析…..........…..……............…...…..................……...…·······14 • 7.5 风险控制措施带来的风险……………………………………………………··14 • 7.6 风险控制的完整性......…………..........…..……...….......………·…·········14 • 8 总体残留风险评估............…....................…..….....…...……........…······14 • 9 风险管理审查……...............…...............…..……...….......…·……·············15 • 10 生产和后期制作活动·…..……·….......…..……..….......…·………···········15 • 10.1 -舟�································································································15 • 10.2信息收集·······················································································15
• .目...>U..L_吉._·····································································iv
. 介绍··········································································································vi
国际标准
ISO 标准 14971
第三版
2019-12
医疗设备—风险管理在医疗设备中的应用
曰四小
版权保护的文件
©ISO 2019
版权所有。 除非另有说明, 或者在实施时需要,否则,未经事先书面许 可,不得以任何形式或手段,通过电子或机械手段(包括影印或在互联 网或内部网上发布)以任何形式复制或使用本出版物的任何部分。 书面 许可。 可以从以下地址的ISO或请求者所在国家的ISO成员体内请求 许可。 ISO版权局 CP 401•章de Blandonnet 8 CH-1214 Vernier, 日内瓦 电话: +41 22 749 01 11 传真: +41 22 749 09 47 电子邮件: copyright@ 网站: 在瑞士出版
• 7.4 利益风险分析…..........…..……............…...…..................……...…·······14 • 7.5 风险控制措施带来的风险……………………………………………………··14 • 7.6 风险控制的完整性......…………..........…..……...….......………·…·········14 • 8 总体残留风险评估............…....................…..….....…...……........…······14 • 9 风险管理审查……...............…...............…..……...….......…·……·············15 • 10 生产和后期制作活动·…..……·….......…..……..….......…·………···········15 • 10.1 -舟�································································································15 • 10.2信息收集·······················································································15
• .目...>U..L_吉._·····································································iv
. 介绍··········································································································vi